Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies

American Journal of Kidney Diseases

Volumn 66, Issue 2, 2015, Pages 258-265

  Da, Jingjing ^a,b   Xie, Xinfang ^a   Wolf, Myles ^c   Disthabanchong, Sinee ^d   Wang, Jinwei ^a   Zha, Yan ^b   Lv, Jicheng ^a   Zhang, Luxia ^a   Wang, Haiyan ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

Author keywords

chronic kidney disease (CKD); disease progression; disease trajectory; Index Words Serum phosphorus; kidney failure; meta analysis; mortality; non dialysis dependent CKD; phosphorus homeostasis; prognosis; renal outcome

Indexed keywords

CREATININE; PHOSPHORUS;

ADVERSE OUTCOME; ARTICLE; CHRONIC KIDNEY DISEASE; COCHRANE LIBRARY; COHORT ANALYSIS; CONFOUNDING VARIABLE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; EMBASE; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MEDLINE; MORTALITY; PHOSPHATE BLOOD LEVEL; RISK ASSESSMENT; SYSTEMATIC REVIEW; BLOOD; CHRONIC KIDNEY FAILURE; META ANALYSIS; PROGNOSIS;

COHORT STUDIES; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; PHOSPHORUS; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84937967529     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2015.01.009     Document Type: Article

References (35)

1. V. Jha, G. Garcia-Garcia, K. Iseki, and et al. Chronic kidney disease: global dimension and perspectives Lancet 382 9888 2013 260 272
2. R.J. Wilson Renal excretion of calcium and sodium in acute nephritis Br Med J 4 5685 1969 713 715
3. W. Yang, D. Xie, A.H. Anderson, and et al. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study Am J Kidney Dis 63 2 2014 236 243
4. A. Meguid El Nahas, and A.K. Bello Chronic kidney disease: the global challenge Lancet 365 9456 2005 331 340
5. M. Cozzolino, G. Gentile, S. Mazzaferro, D. Brancaccio, P. Ruggenenti, and G. Remuzzi Blood pressure, proteinuria, and phosphate as risk factors for progressive kidney disease: a hypothesis Am J Kidney Dis 62 5 2013 984 992
6. S.C. Palmer, A. Hayen, P. Macaskill, and et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis JAMA 305 11 2011 1119 1127
7. N. Voormolen, M. Noordzij, D.C. Grootendorst, and et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients Nephrol Dial Transplant 22 10 2007 2909 2916
8. R. Mehrotra, C.A. Peralta, S.C. Chen, and et al. No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease Kidney Int 84 5 2013 989 997
9. D.F. Stroup, J.A. Berlin, S.C. Morton, and et al. Meta-analysis of Observational Studies in Epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group JAMA 283 15 2000 2008 2012
10. Centre for Reviews and Dissemination Systematic Reviews: CRD's Guidance for Undertaking Reviews in Healthcare 2008 Centre for Reviews and Dissemination York, UK
11. J.A. Berlin, M.P. Longnecker, and S. Greenland Meta-analysis of epidemiologic dose-response data Epidemiology 4 3 1993 218 228
12. N. Hartemink, H.C. Boshuizen, N.J. Nagelkerke, M.A. Jacobs, and H.C. van Houwelingen Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2 Am J Epidemiol 163 11 2006 1042 1052
13. R.J. Hardy, and S.G. Thompson A likelihood approach to meta-analysis with random effects Stat Med 15 6 1996 619 629
14. J. IntHout, J.P. Ioannidis, and G.F. Borm The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method BMC Med Res Methodol 14 2014 25
15. B. Kestenbaum, J.N. Sampson, K.D. Rudser, and et al. Serum phosphate levels and mortality risk among people with chronic kidney disease J Am Soc Nephrol 16 2 2005 520 528
16. S. Schwarz, B.K. Trivedi, K. Kalantar-Zadeh, and C.P. Kovesdy Association of disorders in mineral metabolism with progression of chronic kidney disease Clin J Am Soc Nephrol 1 4 2006 825 831
17. C. Zoccali, P. Ruggenenti, A. Perna, and et al. Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition J Am Soc Nephrol 22 10 2011 1923 1930
18. J.J. Scialla, B.C. Astor, T. Isakova, H. Xie, L.J. Appel, and M. Wolf Mineral metabolites and CKD progression in African Americans J Am Soc Nephrol 24 1 2013 125 135
19. C.P. Kovesdy, J.E. Anderson, and K. Kalantar-Zadeh Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease Clin Nephrol 73 4 2010 268 275
20. K. Chartsrisak, K. Vipattawat, M. Assanatham, and et al. Mineral metabolism and outcomes in chronic kidney disease stage 2-4 patients BMC Nephrol 14 2013 14
21. D.H. Smith, E.S. Johnson, M.L. Thorp, A. Petrik, X. Yang, and D.K. Blough Outcomes predicted by phosphorous in chronic kidney disease: a retrospective CKD-inception cohort study Nephrol Dial Transplant 25 1 2010 166 174
22. D. Fliser, B. Kollerits, U. Neyer, and et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study J Am Soc Nephrol 18 9 2007 2600 2608
23. H. Eddington, R. Hoefield, S. Sinha, and et al. Serum phosphate and mortality in patients with chronic kidney disease Clin J Am Soc Nephrol 5 12 2010 2251 2257
24. V. Menon, T. Greene, A.A. Pereira, and et al. Relationship of phosphorus and calcium-phosphorus product with mortality in CKD Am J Kidney Dis 46 3 2005 455 463
25. G.A. Block, T.E. Hulbert-Shearon, N.W. Levin, and F.K. Port Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 4 1998 607 617
26. M. Kuro-o Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism Nat Rev Nephrol 9 11 2013 650 660
27. S.R. Khan Crystal-induced inflammation of the kidneys: results from human studies, animal models, and tissue-culture studies Clin Exp Nephrol 8 2 2004 75 88
28. G.S. Di Marco, M. Konig, C. Stock, and et al. High phosphate directly affects endothelial function by downregulating annexin II Kidney Int 83 2 2013 213 222
29. T. Koizumi, K. Murakami, H. Nakayama, T. Kuwahara, and O. Yoshinari Role of dietary phosphorus in the progression of renal failure Biochem Biophys Res Commun 295 4 2002 917 921
30. M. Cozzolino, A.S. Dusso, H. Liapis, and et al. The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats J Am Soc Nephrol 13 9 2002 2299 2308
31. M.S. Razzaque The FGF23-klotho axis: endocrine regulation of phosphate homeostasis Nat Rev Endocrinol 5 11 2009 611 619
32. J.P. Forman, J.S. Williams, and N.D. Fisher Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans Hypertension 55 5 2010 1283 1288
33. A. Tomaschitz, S. Pilz, E. Ritz, and et al. Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study Clin Chim Acta 411 17-18 2010 1354 1360
34. L. Tang, K. Both, and R. Taylor ACE inhibition and fibroblast growth factor in cultured human vascular smooth muscle Vasc Med 4 3 1999 129 134
35. M.H. de Borst, M.G. Vervloet, P.M. ter Wee, and G. Navis Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease J Am Soc Nephrol 22 9 2011 1603 1609